Don’t forget you can visit MyAlerts to manage your alerts at any time.
By Aleeza Furman | April 1, 2024
"Within the next several months, the court will be closing the Risperdal, Essure and Elmiron mass tort programs, as the lawyers and self-represented parties work through the remaining cases on the docket," Judge Joshua Roberts, head of the Philadelphia Court of Common Pleas Complex Litigation Center, said.
4 minute read
By Charles Toutant | March 29, 2024
A 2020 verdict allowed Teva and other companies to produce generic versions of Vascepa. But Teva allegedly had to scale back its launch because of an inability to obtain the key ingredient, the suit said.
4 minute read
By Amanda Bronstad | March 18, 2024
U.S. District Judge Dan Polster on Monday declined to disqualify Motley Rice from dozens of opioid cases, but said he was "very uncomfortable" with its government client arrangements.
5 minute read
By Amanda Bronstad | March 15, 2024
Express Scripts Inc., a pharmacy benefit manager facing upcoming bellwether trials over the opioid crisis, filed a March 13 brief referencing a subpoena that Motley Rice member Linda Singer sent to the company on behalf of the city of Chicago.
4 minute read
By Amanda Bronstad | March 15, 2024
The proliferation of advertising on social media for Ozempic and related drugs will be a key part of the lawsuits against Novo Nordisk and Eli Lilly.
6 minute read
By Aleeza Furman | March 15, 2024
"What I want is to avoid asking for continuances and asking for delay and asking for new dates. Just pick your poison and stick with it," Pratter told the approximately 70 people gathered in her courtroom Thursday.
4 minute read
By Trudy Knockless | March 13, 2024
"I love the fast pace and urgency," said Andy Rittenberg, the newly appointed general counsel of Coherus BioSciences. "We have a lot on our plates and accomplish a lot with a small team."
2 minute read
By Chris O'Malley | March 11, 2024
Anat Hakim joined Lilly in 2020, just before the company's stock began a long ascent that has more than quadrupled its value—pushing the company's market capitalization past Tesla's.
2 minute read
By Aleeza Furman | March 11, 2024
The first trial in the mass tort had been scheduled to begin Monday, but most of the program's cases were resolved through confidential settlements in the last six months, according to Kline & Specter partner Tobi Millrood, who serves as plaintiffs liaison counsel in the matter.
3 minute read
By Avalon Zoppo | March 6, 2024
The court found the advocacy group alleging the program was discriminatory lacked standing.
5 minute read
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS